Find your next paid study

Stanford UniversityNCT04256018

~$75 – $2,000

Actual pay is set by the research site.

Optimal Targeted High-definition tDCS for Reducing Post-stroke Upper Limb Motor Impairments

Non-invasive, non-pharmaceutical technologies that augment routine clinical practice for brain diseases and manage chronic symptoms have advanced rapidly over …

Hemiparetic Stroke

Carle Foundation HospitalNCT07599774

Actual pay is set by the research site.

Phase 3

A Randomized Trial to Evaluate Sequential vs Simultaneous Spectacles Plus Patching for Amblyopia in Children 3 to <13 Years Old

A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, fi…

Amblyopia

Jaeb Center for Health ResearchNCT04378790

~$50 – $2,250

Actual pay is set by the research site.

Elucidating the Effect of Dietary Stearic Acid on the Regional Heterogeneity of the Gut Microbiome and Metabolome: Focus on Bile Acid Metabolism

Stearic acid and palmitic acid are two common consumed saturated fatty acids found in foods. Palmitic acid is associated with increases in blood cholesterol, w…

CVD Risk

Tufts UniversityNCT07766915

Actual pay is set by the research site.

Algorithms for Programming DBS Systems for ET

Deep brain stimulation (DBS) targeting the Vim thalamus (ventralis intermedius nucleus) is an FDA-approved neuromodulation therapy for treating postural and ac…

Essential Tremor

University of MinnesotaNCT03984643

Actual pay is set by the research site.

Vapors; InhalationCancerVolatile Organic Compounds

Addressing Tetrachloroethylene Exposure in an Impacted Community: Residents' Concerns, Neurotoxic Effects, and Exposure Reduction

Groundwater in Martinsville, IN, is contaminated by volatile organic compounds (VOCs), tetrachloroethylene (PCE) and trichloroethylene (TCE). Indoor air in som…

Purdue UniversityNCT05819996

Actual pay is set by the research site.

Pregnancy PretermPremature BirthPregnancy Complications+2 more

Promoting Shared Decision Making in Periviable Care: A Randomized Controlled Trial of the Periviable GOALS Decision Support Tool

The Periviable GOALS (Getting Optimal Alignment around Life Support) decision support tool (DST) is meant to facilitate informed shared decision-making regardi…

Indiana UniversityNCT05264779

Actual pay is set by the research site.

The Parkinson's Genetic Research Study (PaGeR)

The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (…

Parkinson's Disease

University of WashingtonNCT01558479

Actual pay is set by the research site.

Opti Gait Wearable Gait Tracker: Pilot Trial l With Healthy Older Adults

The purpose of this observational study is to test a shoe mounted gait monitoring device that was refined with the input of older adults and assess the efficac…

Seniors

University of Wisconsin, MadisonNCT07158580

Actual pay is set by the research site.

Phase 1

Pilot, Open-Label Study Evaluating the Safety and Feasibility of Using Rescue Therapies for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome

This is a pilot, open-label study to assess the safety and feasibility of using investigational drug(s) as rescue therapies for CAR T cell related CRS and HLH-…

CRS - Cytokine Release SyndromeHLH

University of PennsylvaniaNCT05306080

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

Prospective Placebo-Controlled Trial of Intramuscular Steroid Administration for the Treatment of Unexplained Chronic Cough

The primary goal of this study is to test the hypothesis that injecting steroid intramuscularly is an effective treatment for unexplained chronic cough. This w…

Chronic Cough (CC)Laryngeal DiseaseCoughing

Medical University of South CarolinaNCT06634823

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Intravesical Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in Participants With Intermediate-risk Non-muscle Invasive Bladder Cancer (NMIBC)

The goal of the study is to learn about the safety of Sacituzumab Tirumotecan and if people can tolerate it when given in the bladder and find the highest dose…

Non-Muscle Invasive Bladder Cancer